The Role of Vascular Endothelial Growth Factor in Wound Healing

Journal of Surgical Research

Volumn 153, Issue 2, 2009, Pages 347-358

  Bao, Philip ^a   Kodra, Arber ^b   Tomic Canic, Marjana ^c   Golinko, Michael S ^d   Ehrlich, H Paul ^e   Brem, Harold ^d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

angiogenesis; epithelialization; fibroblast; keratinocyte; VEGF; wound healing

Indexed keywords

GELATINASE A; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; PLATELET DERIVED GROWTH FACTOR BB; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANASTOMOSIS; ANGIOGENESIS; BASEMENT MEMBRANE; CARDIOVASCULAR DISEASE; CELL GROWTH; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; EPITHELIZATION; HUMAN; KERATINOCYTE; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; WOUND HEALING;

ANIMALS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 64849116779     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.04.023     Document Type: Review

References (150)

1. Amlung S.R., Miller W.L., and Bosley L.M. The 1999 National Pressure Ulcer Prevalence Survey: A benchmarking approach. Adv Skin Wound Care 14 (2001) 297
2. Hospitalizations Related to Pressure Sores, 2003. Agency for Healthcare Research and Quality, 2006. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb3.pdf Accessed: August 31, 2006
3. Coon W.W., Willis III P.W., and Keller J.B. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation 48 (1973) 839
4. Consensus Development Conference on Diabetic Foot Wound Care: 7-8 April 1999, Boston, Massachusetts. American Diabetes Association. Diabetes Care 22 (1999) 1354
5. Calle-Pascual A., Garcia-Torre N., Moraga I., et al. Epidemiology of nontraumatic lower-extremity amputation in area 7. Madrid, between 1989 and 1999: A population-based study. Diabetes Care 24 (2001) 1686
6. Strauss M.B., and Aksenov I.V. Evaluation of diabetic wound classifications and a new wound score. Clin Orthopaed Relat Res 439 (2005) 79
7. Ho D.Q., Bello Y.M., Grove G.L., et al. A pilot study of noninvasive methods to assess healed acute and chronic wounds. Dermatol Surg 26 (2000) 42
8. Li J., Chen J., and Kirsner R. Pathophysiology of acute wound healing. Clin Dermatol 25 (2007) 9
9. Carter K. Growth factors: the wound healing therapy of the future. Br J Commu Nurs 8 (2003) S15 S8, S22
10. Debus E.S., Schmidt K., Ziegler U.E., et al. [The role of growth factors in wound healing]. Zentralbl Chir 125 Suppl 1 (2000) 49
11. Grazul-Bilska A.T., Johnson M.L., Bilski J.J., et al. Wound healing: The role of growth factors. Drugs Today (Barc) 39 (2003) 787
12. Ferrara N., and Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161 (1989) 851
13. Plouet J., Schilling J., and Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J 8 (1989) 3801
14. Gospodarowicz D., Abraham J.A., and Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 86 (1989) 7311
15. Leung D.W., Cachianes G., Kuang W.J., et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246 (1989) 1306
16. Keck P.J., Hauser S.D., Krivi G., et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246 (1989) 1309
17. Connolly D.T., Heuvelman D.M., Nelson R., et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84 (1989) 1470
18. Yoshida A., Anand-Apte B., and Zetter B.R. Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors 13 (1996) 57
19. Noiri E., Lee E., Testa J., et al. Podokinesis in endothelial cell migration: role of nitric oxide. Am J Physiol 274 (1998) C236
20. Senger D.R., Galli S.J., Dvorak A.M., et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219 (1983) 983
21. Senger D.R., Connolly D.T., Van de Water L., et al. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 50 (1990) 1774
22. Brkovic A., and Sirois M.G. Vascular permeability induced by VEGF family members in vivo: Role of endogenous PAF and NO synthesis. J Cell Biochem 100 (2007) 727
23. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77 (1999) 527
24. Gavard J., and Gutkind J.S. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8 (2006) 1223
25. Griffoen A.W., and Molema G. Angiogenesis: Potentials for pharmacological interventionin the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52 (2000) 237
26. Yamagishi S., Yonekura H., Yamamoto Y., et al. Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions. Lab Invest 79 (1999) 501
27. Stojadinovic O.K.A., Golinko M., Tomic-Canic M., et al. A novel, non-angiogenic mechanism of VEGF: Stimulation of keratinocyte and fibroblast migration. Wound Repair Regen 15 (2007) A30
28. Ladin D. Becaplermin gel (PDGF-BB) as topical wound therapy. Plastic Surgery Educational Foundation DATA Committee. Plast Reconstr Surg 105 (2000) 1230
29. Falanga V. Apligraf treatment of venous ulcers and other chronic wounds. J Dermatol 25 (1998) 812
30. Brem H., Balledux J., Sukkarieh T., et al. Healing of venous ulcers of long duration with a bilayered living skin substitute: results from a general surgery and dermatology department. Dermatol Surg 27 (2001) 915
31. Brem H., Balledux J., Bloom T., et al. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: A new paradigm in wound healing. Arch Surg 135 (2000) 627
32. Tischer E., Mitchell R., Hartman T., et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266 (1991) 11947
33. Houck K.A., Ferrara N., Winer J., et al. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5 (1991) 1806
34. Houck K.A., Leung D.W., Rowland A.M., et al. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267 (1992) 26031
35. Poltorak Z., Cohen T., Sivan R., et al. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem 272 (1997) 7151
36. Maruyama K., Asai J., Ii M., et al. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 170 (2007) 1178
37. Uchida K., Uchida S., Nitta K., et al. Glomerular endothelial cells in culture express and secrete vascular endothelial growth factor. Am J Physiol 266 (1994) F81
38. Namiki A., Brogi E., Kearney M., et al. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 270 (1995) 31189
39. Nissen N.N., Polverini P.J., Koch A.E., et al. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 152 (1998) 1445
40. Brogi E., Wu T., Namiki A., and Isner J.M. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90 (1994) 649
41. Stavri G.T., Zachary I.C., Baskerville P.A., et al. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation 92 (1995) 11
42. Banks R.E., Forbes M.A., Kinsey S.E., et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology. Br J Cancer 77 (1998) 956
43. Gaudry M., Bregerie O., Andrieu V., et al. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 90 (1997) 4153
44. Berse B., Brown L.F., Van de Water L., et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3 (1992) 211
45. de Vries C., Escobedo J.A., Ueno H., et al. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255 (1992) 989
46. Thomas K.A. Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 271 (1996) 603
47. Terman B.I., Dougher-Vermazen M., Carrion M.E., et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187 (1992) 1579
48. Soker S., Fidder H., Neufeld G., et al. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. J Biol Chem 271 (1996) 5761
49. Olander J.V., Connolly D.T., and DeLarco J.E. Specific binding of vascular permeability factor to endothelial cells. Biochem Biophys Res Commun 175 (1991) 68
50. Peters K.G., De Vries C., and Williams L.T. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 90 (1993) 8915
51. Breier G., Damert A., Plate K.H., et al. Angiogenesis in embryos and ischemic diseases. Thromb Haemost 78 (1997) 678
52. Barleon B., Hauser S., Schollmann C., et al. Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells. J Cell Biochem 54 (1994) 56
53. Shalaby F., Rossant J., Yamaguchi T.P., et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376 (1995) 62
54. Fong G.H., Rossant J., Gertsenstein M., et al. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376 (1995) 66
55. Waltenberger J., Claesson-Welsh L., Siegbahn A., et al. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269 (1994) 26988
56. Malavaud B., Tack I., Jonca F., et al. Activation of Flk-1/KDR mediates angiogenesis but not hypotension. Cardiovasc Res 36 (1997) 276
57. Barleon B., Sozzani S., Zhou D., et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87 (1996) 3336
58. Wang H., and Keiser J.A. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: Role of flt-1. Circ Res 83 (1998) 832
59. Katoh O., Tauchi H., Kawaishi K., et al. Expression of the vascular endothelial growth factor (VEGF) receptor gene. KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res 55 (1995) 5687
60. Pajusola K., Aprelikova O., Korhonen J., et al. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res 52 (1992) 5738
61. Galland F., Karamysheva A., Mattei M.G., et al. Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene. Genomics 13 (1992) 475
62. Veikkola T., Jussila L., Makinen T., et al. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 20 (2001) 1223
63. Enholm B., Karpanen T., Jeltsch M., et al. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ Res 88 (2001) 623
64. Folkman J., and Brem H. Angiogenesis and inflammation. In: Gallin J., Goldstein I., and Snyderman R. (Eds). Inflammation: Basic Principles and Clinical Correlates. 2nd ed. (1992), Raven Press, New York 821-839
65. Murohara T., Horowitz J.R., Silver M., et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97 (1998) 99
66. Ku D.D., Zaleski J.K., Liu S., et al. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 265 (1993) H586
67. van der Zee R., Murohara T., Luo Z., et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 95 (1997) 1030
68. Li J., Hampton T., Morgan J.P., et al. Stretch-induced VEGF expression in the heart. J Clin Invest 100 (1997) 18
69. Brock T.A., Dvorak H.F., and Senger D.R. Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. Am J Pathol 138 (1991) 213
70. Unemori E.N., Ferrara N., Bauer E.A., et al. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 153 (1992) 557
71. Pepper M.S., Ferrara N., Orci L., et al. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181 (1991) 902
72. Yebra M., Parry G.C., Stromblad S., et al. Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration. J Biol Chem 271 (1996) 29393
73. Suzuma K., Takagi H., Otani A., et al. Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells. Invest Ophthalmol Vis Sci 39 (1998) 1028
74. Senger D.R., Ledbetter S.R., Claffey K.P., et al. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol 149 (1996) 293
75. Morbidelli L., Chang C.H., Douglas J.G., et al. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 270 (1996) H411
76. Pepper M.S., Ferrara N., Orci L., et al. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189 (1992) 824
77. Goto F., Goto K., Weindel K., et al. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 69 (1993) 508
78. Watanabe Y., Lee S.W., Detmar M., et al. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells. Oncogene 14 (1997) 2025
79. Gerber H.P., McMurtrey A., Kowalski J., et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273 (1998) 30336
80. Spyridopoulos I., Brogi E., Kearney M., et al. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: Balance between growth and death signals. J Mol Cell Cardiol 29 (1997) 1321
81. Watanabe Y., and Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation. Exp Cell Res 233 (1997) 340
82. Abid M.R., Shih S.C., Otu H.H., et al. A novel class of vascular endothelial growth factor-responsive genes that require forkhead activity for expression. J Biol Chem 281 (2006) 35544
83. Vinci M.C., Visentin B., Cusinato F., et al. Effect of vascular endothelial growth factor and epidermal growth factor on iatrogenic apoptosis in human endothelial cells. Biochem Pharmacol 67 (2004) 277
84. Abid M.R., Guo S., Minami T., et al. Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells. Arterioscler Thromb Vasc Biol 24 (2004) 294
85. Zheng J., Wen Y., Song Y., et al. Activation of multiple signaling pathways is critical for fibroblast growth factor 2- and vascular endothelial growth factor-stimulated ovine fetoplacental endothelial cell proliferation. Biol Reprod 78 (2008) 143
86. Gratton J.P., Morales-Ruiz M., Kureishi Y., et al. Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem 276 (2001) 30359
87. Brem H., and Folkman J. Angiogenesis and basic fibroblast growth factor during wound healing. In: Friedlander G.E., and Lane J.M. (Eds). Bone Formation and Repair (1994), American Academy of Orthopedic Surgeons, Rosemont, IL 213-222
88. Brem H., Ehrlich H.P., Tsakayannis D., et al. Delay of wound healing by the angiogenesis inhibitor TNP-470. Surg Forum 48 (1997) 714
89. McGrath M.H., and Emery III J.M. The effect of inhibition of angiogenesis in granulation tissue on wound healing and the fibroblast. Ann Plast Surg 15 (1985) 105
90. Brem H., Tsakayannis D., and Folkman J. Time dependent suppression of wound healing with the angiogenesis inhibitor, AGM 1470. J Cell Biol 115 (1991) 403a
91. Mohle R., Green D., and Moore M.A. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 94 (1997) 663
92. Leibovich S.J., Polverini P.J., Shepard H.M., et al. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329 (1987) 630
93. Frank S., Hubner G., Breier G., et al. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 270 (1995) 12607
94. Takahashi M., Kawabe T., Ogura K., et al. Expression of vascular endothelial growth factor at the human gastric ulcer margin and in cultured gastric fibroblasts: A new angiogenic factor for gastric ulcer healing. Biochem Biophys Res Commun 234 (1997) 493
95. Niiinikoski J., Heughan C., and Hunt T. Oxygen and carbon dioxide tensions in experimental wounds. Surg Gynecol Obstet 133 (1971) 1003
96. Silver I.A. The measurement of oxygen tension in healing tissue. Progr Respir Res 3 (1969) 124
97. Detmar M., Brown L.F., Berse B., et al. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J Invest Dermatol 108 (1997) 263
98. Levy A.P., Levy N.S., Loscalzo J., et al. Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res 76 (1995) 758
99. Shweiki D., Itin A., Soffer D., et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359 (1992) 843
100. Hashimoto E., Kage K., Ogita T., et al. Adenosine as an endogenous mediator of hypoxia for induction of vascular endothelial growth factor mRNA in U-937 cells. Biochem Biophys Res Commun 204 (1994) 318
101. Takagi H., King G.L., Ferrara N., et al. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Invest Ophthalmol Vis Sci 37 (1996) 1311
102. Levy A.P., Levy N.S., and Goldberg M.A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 271 (1996) 2746
103. Levy A.P., Levy N.S., Wegner S., et al. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270 (1995) 13333
104. Stein I., Neeman M., Shweiki D., et al. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 15 (1995) 5363
105. Elson D.A., Ryan H.E., Snow J.W., et al. Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res 60 (2000) 6189
106. Mace K.A., Yu D.H., Paydar K.Z., et al. Sustained expression of Hif-1alpha in the diabetic environment promotes angiogenesis and cutaneous wound repair. Wound Repair Regen 15 (2007) 636
107. Knighton D.R., Silver I.A., and Hunt T.K. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery 90 (1981) 262
108. Brown L.F., Yeo K.T., Berse B., et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176 (1992) 1375
109. Shukla A., Dubey M.P., Srivastava R., et al. Differential expression of proteins during healing of cutaneous wounds in experimental normal and chronic models. Biochem Biophys Res Commun 244 (1998) 434
110. Howard E.W., Soo C., Hunter S., et al. Differences in MMP and TIMP gene expression during wound repair. Surg Forum 48 (1997) 688
111. Nissen N.N., Polverini P.J., Gamelli R.L., et al. Basic fibroblast growth factor mediates angiogenic activity in early surgical wounds. Surgery 119 (1996) 457
112. Bikfalvi A., Klein S., Pintucci G., et al. Biological roles of fibroblast growth factor-2. Endocr Rev 18 (1997) 26
113. Brem H., Shing Y., Watanabe Y., et al. Temporal expression of basic fibroblast growth factor during wound healing. Surg Forum 43 (1992) 664
114. Seghezzi G., Patel S., Ren C.J., et al. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis. J Cell Biol 141 (1998) 1659
115. Mandriota S.J., and Pepper M.S. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. J Cell Sci 110 Pt. 18 (1997) 2293
116. Clark R.A., Tonnesen M.G., Gailit J., et al. Transient functional expression of alphaVbeta 3 on vascular cells during wound repair. Am J Pathol 148 (1996) 1407
117. Christofidou-Solomidou M., Bridges M., Murphy G.F., et al. Expression and function of endothelial cell alpha v integrin receptors in wound-induced human angiogenesis in human skin/SCID mice chimeras. Am J Pathol 151 (1997) 975
118. Isner J.M., Pieczek A., Schainfeld R., et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348 (1996) 370
119. Baumgartner I., Pieczek A., Manor O., et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97 (1998) 1114
120. Isner J.M., Baumgartner I., Rauh G., et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results. J Vasc Surg 28 (1998) 964 discussion 73
121. Losordo D.W., Vale P.R., Symes J.F., et al. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98 (1998) 2800
122. Laitinen M., Hartikainen J., Hiltunen M.O., et al. Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Hum Gene Ther 11 (2000) 263
123. Rosengart T.K., Lee L.Y., Patel S.R., et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100 (1999) 468
124. Rosengart T.K., Lee L.Y., Patel S.R., et al. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann Surg 230 (1999) 466 discussion 70
125. Olerud J.E., Odland G.F., Burgess E.M., et al. A model for the study of wounds in normal elderly adults and patients with peripheral vascular disease or diabetes mellitus. J Surg Res 59 (1995) 349
126. Wyss C.R., Matsen III F.A., Simmons C.W., et al. Transcutaneous oxygen tension measurements on limbs of diabetic and nondiabetic patients with peripheral vascular disease. Surgery 95 (1984) 339
127. Allen D.B., Maguire J.J., Mahdavian M., et al. Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch Surg 132 (1997) 991
128. Hopf H.W., Hunt T.K., West J.M., et al. Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch Surg 132 (1997) 997 discussion 995
129. Pecoraro R.E., Ahroni J.H., Boyko E.J., et al. Chronology and determinants of tissue repair in diabetic lower-extremity ulcers. Diabetes 40 (1991) 1305
130. Marin P., Andersson B., Krotkiewski M., et al. Muscle fiber composition and capillary density in women and men with NIDDM. Diabetes Care 17 (1994) 382
131. Brem H., and Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 117 (2007) 1219
132. Stehouwer C.D., Lambert J., Donker A.J., et al. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 34 (1997) 55
133. Rivard A., Silver M., Chen D., et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 154 (1999) 355
134. Sone H., Kawakami Y., Okuda Y., et al. Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells. Biochem Biophys Res Commun 221 (1996) 193
135. Albertson S., Hummel III R.P., Breeden M., et al. PDGF and FGF reverse the healing impairment in protein-malnourished diabetic mice. Surgery 114 (1993) 368 discussion 72
136. VEGF enhances angiogenic response in experimental wounds as measured by tensile properties of the wound, increased epithelialization, and decreased time to closure. Wounds (2007). http://www.woundsresearch.com/article/6976 Accessed: March 31, 2008
137. Smiell J.M., Wieman T.J., Steed D.L., et al. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen 7 (1999) 335
138. Dormandy A. Pathophysiology of venous leg ulceration. Int J Microcirc Clin Exp 17 Suppl 1 (1997) 2
139. Mirshahi S., Soria J., Mirshahi M., et al. Expression of elastase and fibrin in venous leg ulcer biopsies: A pilot study of pentoxifylline versus placebo. J Cardiovasc Pharmacol 25 Suppl 2 (1995) S101
140. Vaalamo M., Weckroth M., Puolakkainen P., et al. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol 135 (1996) 52
141. Vaalamo M., Leivo T., and Saarialho-Kere U. Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum Pathol 30 (1999) 795
142. Barone E.J., Yager D.R., Pozez A.L., et al. Interleukin-1alpha and collagenase activity are elevated in chronic wounds. Plast Reconstr Surg 102 (1998) 1023 discussion 1028
143. Shoab S.S., Scurr J.H., and Coleridge-Smith P.D. Increased plasma vascular endothelial growth factor among patients with chronic venous disease. J Vasc Surg 28 (1998) 535
144. Peschen M., Grenz H., Brand-Saberi B., et al. Increased expression of platelet-derived growth factor receptor alpha and beta and vascular endothelial growth factor in the skin of patients with chronic venous insufficiency. Arch Dermatol Res 290 (1998) 291
145. Schubert V. Hypotension as a risk factor for the development of pressure sores in elderly subjects. Age Ageing 20 (1991) 255
146. Schubert V., and Fagrell B. Local skin pressure and its effects on skin microcirculation as evaluated by laser-Doppler fluxmetry. Clin Physiol 9 (1989) 535
147. Schubert V., Schubert P.A., Breit G., et al. Analysis of arterial flowmotion in spinal cord injured and elderly subjects in an area at risk for the development of pressure sores. Paraplegia 33 (1995) 387
148. Mawson A.R., Siddiqui F.H., and Biundo Jr. J.J. Enhancing host resistance to pressure ulcers: A new approach to prevention. Prev Med 22 (1993) 433
149. Robson M.C., Phillips L.G., Lawrence W.T., et al. The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores. Ann Surg 216 (1992) 401 discussion 406
150. Robson M.C., Hill D.P., Smith P.D., et al. Sequential cytokine therapy for pressure ulcers: Clinical and mechanistic response. Ann Surg 231 (2000) 600